Impacts on Causes of Perinatal Death After Safer Baby Bundle Implementation in Victoria, Australia

Keeth L B Mayakaduwage1,2,3, Tanya Farrell2, Roshan J Selvaratnam1,2,3

  • 1The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia.

Insights

The Safer Baby Bundle (SBB) reduced unexplained stillbirths and those from specific perinatal conditions. This initiative shows promise for national expansion to further decrease perinatal mortality.

Area of Science:

  • Perinatal Health
  • Public Health Interventions
  • Obstetrics and Gynecology

Background:

  • The Safer Baby Bundle (SBB) was implemented in June 2019.
  • SBB is associated with reduced perinatal mortality.
  • Early impact assessment on specific causes of death is crucial for intervention refinement.

Purpose of the Study:

  • To evaluate changes in the causes of perinatal death before and after SBB implementation in Victoria, Australia.
  • To assess the effectiveness of the SBB in reducing stillbirths and neonatal deaths.
  • To identify specific causes of perinatal death impacted by the SBB.

Main Methods:

  • Retrospective population-based cohort study of singleton births (≥28 weeks gestation) from 2014 to 2020.
  • Exclusion of births with congenital anomalies and terminations.
  • Comparison of perinatal death causes in pre-SBB (Jan 2014–Jun 2019) and post-SBB (Jul 2019–Dec 2020) periods using chi-squared tests.

Main Results:

  • At SBB sites, stillbirths due to specific perinatal conditions decreased (RR: 0.30) and unexplained antepartum fetal deaths declined (RR: 0.53).
  • No significant changes in any cause of neonatal death were observed at SBB sites.
  • Non-SBB sites showed increased stillbirths from placental dysfunction and antepartum hemorrhage, but decreased neonatal deaths from hypoxic events and neurological conditions.

Conclusions:

  • SBB implementation significantly reduced unexplained stillbirths and those from specific perinatal conditions.
  • No increase in any cause of neonatal death was observed, supporting SBB's safety.
  • Findings support national expansion of SBB, with continued focus on remaining stillbirth causes.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
2.4K